Jin Yang Pharmaceutical's latest marketcap:
As of 06/26/2025, Jin Yang Pharmaceutical's market capitalization has reached $55.71 M. According to our data, Jin Yang Pharmaceutical is the 28797th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 55.71 M |
| Revenue (ttm) | 85.51 M |
| Net Income (ttm) | 22 M |
| Shares Out | 11.81 M |
| EPS (ttm) | 1.85 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/27/2024 |
| Earnings Date | n/a |
Jin Yang Pharmaceutical's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | ₩55.71 M | 12.1% | 28797 |
| 12/30/2024 | ₩66.5 B | -0.45% | 28795 |
| 12/28/2023 | ₩66.81 B | -4.91% | 27568 |
| 12/29/2022 | ₩70.26 B | -10.72% | 26137 |
| 12/30/2021 | ₩78.69 B | 0.57% | 25812 |
| 12/30/2020 | ₩78.24 B | 59.09% | 22567 |
| 12/30/2019 | ₩49.18 B | 17.02% | 22807 |
| 12/28/2018 | ₩42.03 B | -18.26% | 22521 |
| 12/28/2017 | ₩51.42 B | -10.51% | 21809 |
| 12/29/2016 | ₩57.45 B | 11.98% | 19659 |
Company Profile
About Jin Yang Pharmaceutical Co., Ltd.
Jin Yang Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company specializing in a diverse range of medical products. Established in 1971 and headquartered in Seoul, the company serves various therapeutic segments with high-quality medications.
Key Product Offerings
- Anti-Diabetics, Antivirals & Anti-Hypertensives – Treatments for chronic conditions.
- Anti-Coagulants, Antihistamines & Analgesics – Medications for blood clotting, allergies, and pain relief.
- Digestive, Respiratory & Neuropsychiatric System Drugs – Solutions for gastrointestinal, lung, and mental health disorders.
- Genito-Urinary & Anti-Osteoporosis Treatments – Medications for urinary and bone health.
- Antimicrobials & Antibiotics – Infection-fighting drugs.
- Over-the-Counter (OTC) Medications – Including antipyretics and pain relievers.
- Circulatory & Dermatological Products – Treatments for cardiovascular and skin conditions.
- Muscle Relaxants & Anti-Hyperlipidemics – For muscle pain and cholesterol management.
- Multivitamins, Hepatics & Anti-Anemics – Nutritional and blood health supplements.
- Anti-Obesity, Dental Care & Ophthalmic Drugs – Specialized treatments for weight management, oral health, and eye care.
With decades of expertise, Jin Yang Pharmaceutical remains committed to advancing healthcare in South Korea and beyond.
Frequently Asked Questions
-
What is Jin Yang Pharmaceutical's (KOSDAQ-007370) current market cap?As of 06/26/2025, Jin Yang Pharmaceutical (including the parent company, if applicable) has an estimated market capitalization of $55.71 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Jin Yang Pharmaceutical (KOSDAQ-007370) rank globally by market cap?Jin Yang Pharmaceutical global market capitalization ranking is approximately 28797 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.